The company is a specialty pharmaceutical company developing therapies for rare diseases linked to single gene deficiencies. They currently have three pipeline products for developing treatments of various orphan diseases. One of the pipeline products is in Phase II.

Posted Jul 28, 2016

Did you know that social networking is a great way to buy a business? Sign up now and we'll show you how.

By clicking "Sign Up" you confirm that you accept the Terms of Use and Privacy Policy, including cookie use.

Disclaimer: MergerNetwork has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness.